Raia Drogasil (OTCMKTS:RADLY) Shares Gap Up – Here’s What Happened

Raia Drogasil S.A. (OTCMKTS:RADLY) gapped up before the market opened on Monday. The stock had previously closed at $3.80, but opened at $4.1650. Raia Drogasil shares last traded at $4.1650, with a volume of 2,465 shares trading hands.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 price objective for the company in a report on Sunday. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $5.20.

Raia Drogasil Stock Up 2.8%

The stock has a fifty day moving average price of $3.77 and a 200-day moving average price of $3.85. The firm has a market cap of $5.77 billion and a PE ratio of 25.12. The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41.

Raia Drogasil (OTCMKTS:RADLY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.05. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. The firm had revenue of $2.17 billion for the quarter, compared to analysts’ expectations of $2.32 billion. Research analysts expect that Raia Drogasil S.A. will post 0.17 EPS for the current year.

About Raia Drogasil

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.